Juvenile localized scleroderma: a large retrospective cohort study from a tertiary care center

Buğra Han Egeli(Boston Children's Hospital), Fatma Dedeoğlu(Boston Children's Hospital), Ruth Ann Vleugels(Brigham and Women's Hospital), Diana B. Reusch(University of Massachusetts Amherst), Johnathan Dallas(Boston Children's Hospital), Robert P. Sundel(Boston Children's Hospital), Katharina Shaw(University of Pennsylvania), Stephen E. Gellis(Boston Children's Hospital), Mary Beth F. Son(Boston Children's Hospital)
Pediatric Rheumatology
June 6, 2025
10.1186/s12969-025-01116-0
Cited by 3

Related Papers

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
|New England Journal of Medicine|1991|1.2k
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
|JAMA|2021|852
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
|Arthritis & Rheumatology|2020|537
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series
|Arthritis & Rheumatism|2010|465